Literature DB >> 4004484

[Statural growth following irradiation of the central nervous system for medulloblastoma of the posterior fossa. Retrospective analysis of 45 cases].

R Brauner, P Czernichow, R Rappaport, J Lemerle, D Sarrazin, J F Hirsch, D Renier, J M Zucker.   

Abstract

Treatment of medulloblastoma in children with head and spinal irradiation causes growth hormone deficiency and growth retardation. The present study deals with 45 patients presenting a follow-up time superior to 4 years; some of them having reached their final height. The mean final height is 3 standard deviations below normal mean. Growth retardation which occurred in 42 of 45 children, appears to be due to two major factors: 1) GH deficiency in 42 cases as assessed by the arginine insulin tolerance test. 2) Spinal lesions due to irradiation, causing early growth retardation and a reduced trunk length in most of these children. The response to hGH treatment (10 mg/kg/yr) was not sufficient in this group of patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4004484

Source DB:  PubMed          Journal:  Arch Fr Pediatr        ISSN: 0003-9764


  4 in total

1.  Characteristics of growth disturbances in patients with intracranial germinomas of different origins.

Authors:  Bo Li; Jiayi Wang; Jiongxian Yang; Yanong Li; Yanwei Liu; Shuai Liu; Xiaoguang Qiu
Journal:  Childs Nerv Syst       Date:  2021-05-24       Impact factor: 1.475

2.  Polygraphic sleep patterns and growth hormone secretion in children after cranial irradiation.

Authors:  I Fagioli; R Brauner; R Rappaport
Journal:  Eur J Pediatr       Date:  1991-01       Impact factor: 3.183

3.  Final height and insulin-like growth factor-1 in children with medulloblastoma treated with growth hormone.

Authors:  Hyun Wook Chae; Young Seok Park; Dong Seok Kim; Ah Reum Kwon; Ho-Seong Kim; Duk Hee Kim
Journal:  Childs Nerv Syst       Date:  2013-06-18       Impact factor: 1.475

4.  Endocrine disorders following treatment of childhood brain tumours.

Authors:  E A Livesey; P C Hindmarsh; C G Brook; A C Whitton; H J Bloom; J S Tobias; J N Godlee; J Britton
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.